Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
Calithera Biosciences, Inc. (CALA)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
04/17/2023
TAKEDA PHARMACEUTICAL CO LTD
Other (disposition)
Series A Convertible Preferred Stock
1000k
$0.00
$0
See Explanation of Responses
04/17/2023
01/23/2023
Wong Stephanie
See Remarks
Payment of Exercise
Common Stock
317
$0.45
$141.4
01/23/2023
01/23/2023
Molineaux Susan
PRESIDENT & CEO
Payment of Exercise
Common Stock
526
$0.45
$234.6
By Trust
01/23/2023
01/23/2023
Sjogren Eric
SR. VP, DRUG DISCOVERY
Payment of Exercise
Common Stock
279
$0.45
$124.5
01/23/2023
01/23/2023
Molineaux Christopher
SR. VP, DEVELOPMENT
Payment of Exercise
Common Stock
217
$0.45
$96.8
By Trust
01/23/2023
01/23/2023
Kuriakose Emil
CHIEF MEDICAL OFFICER
Payment of Exercise
Common Stock
79
$0.45
$35.2
01/23/2023
07/01/2022
TAKEDA PHARMACEUTICAL CO LTD
Other (disposition)
Series A Convertible Preferred Stock
1000k
$0.00
$0
See Explanation of Responses
07/01/2022
07/01/2022
TAKEDA PHARMACEUTICAL CO LTD
Other (acquisition)
Series A Convertible Preferred Stock
1000k
$0.00
$0
See Explanation of Responses
07/01/2022
06/01/2022
Wolff Henry Ward
Director
Grant
Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
06/01/2022
PAKIANATHAN DEEPIKA
Director
Grant
Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
06/01/2022
Garland J. Scott
Director
Grant
Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
06/01/2022
AGARWAL SUNIL
Director
Grant
Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
06/01/2022
Orford Keith
Director
Grant
Employee Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
06/01/2022
Wise Blake
Director
Grant
Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
06/01/2022
JONES SUZY
Director
Grant
Stock Option (Right to Buy)
20k
$0.20
$4k
06/01/2022
01/25/2022
Parlati Francesco
SR. VP, RESEARCH
Grant
Employee Stock Option (Right to Buy)
165k
$0.44
$72.6k
01/25/2022
01/25/2022
Kuriakose Emil
CHIEF MEDICAL OFFICER
Grant
Employee Stock Option (Right to Buy)
215k
$0.44
$94.6k
01/25/2022
01/25/2022
Orford Keith
Director
Grant
Employee Stock Option (Right to Buy)
40k
$0.44
$17.6k
01/25/2022
01/25/2022
Sjogren Eric
SR. VP, DRUG DISCOVERY
Grant
Employee Stock Option (Right to Buy)
165k
$0.44
$72.6k
01/25/2022
01/25/2022
Molineaux Christopher
SR. VP, DEVELOPMENT
Grant
Employee Stock Option (Right to Buy)
165k
$0.44
$72.6k
01/25/2022
01/25/2022
Molineaux Susan
PRESIDENT & CEO
Grant
Employee Stock Option (Right to Buy)
597.5k
$0.44
$262.9k
01/25/2022
01/25/2022
Wong Stephanie
See Remarks
Grant
Employee Stock Option (Right to Buy)
215k
$0.44
$94.6k
01/25/2022
01/25/2022
Ray Sumita
See Remarks
Grant
Employee Stock Option (Right to Buy)
165k
$0.44
$72.6k
01/25/2022
01/21/2022
Wong Stephanie
See Remarks
Payment of Exercise
Common Stock
5.6k
$0.49
$2.7k
01/21/2022
01/21/2022
Sjogren Eric
SR. VP, DRUG DISCOVERY
Payment of Exercise
Common Stock
4.8k
$0.49
$2.4k
01/21/2022
01/21/2022
Parlati Francesco
SR. VP, RESEARCH
Payment of Exercise
Common Stock
4.8k
$0.49
$2.4k
01/21/2022
01/21/2022
Kuriakose Emil
CHIEF MEDICAL OFFICER
Payment of Exercise
Common Stock
666
$0.49
$327.3
01/21/2022
01/04/2022
Kuriakose Emil
CHIEF MEDICAL OFFICER
Payment of Exercise
Common Stock
3.9k
$0.66
$2.5k
01/04/2022
01/04/2022
Parlati Francesco
SR. VP, RESEARCH
Payment of Exercise
Common Stock
18.1k
$0.66
$11.9k
01/04/2022
01/04/2022
Sjogren Eric
SR. VP, DRUG DISCOVERY
Payment of Exercise
Common Stock
18.1k
$0.66
$11.9k
01/04/2022
01/04/2022
Wong Stephanie
See Remarks
Payment of Exercise
Common Stock
18.1k
$0.66
$11.9k
01/04/2022
11/11/2021
Orford Keith
Director
Sale
Common Stock
48.2k
$0.88
$42.4k
11/10/2021
11/10/2021
Orford Keith
Director
Sale
Common Stock
30k
$0.86
$25.7k
11/10/2021
11/10/2021
DRACHMAN JONATHAN G
Director
Purchase
Common Stock
200k
$0.86
$171.9k
11/10/2021
11/10/2021
Molineaux Susan
PRESIDENT & CEO
Purchase
Common Stock
100k
$0.85
$84.7k
By Trust
11/10/2021
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy